Search Results - "Springett, G.M."

Worse Overall Survival With Preoperative Biliary Drainage in Resectable Pancreatic Cancer Patients.

Authors: Strom, T. Springett, G.M. Meredith, K.L. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS354-S354. 1p.

Subjects: Preoperative care, Pancreatic cancer treatment, Surgical excision, Cancer radiotherapy, Oncology research

Outcomes of Adjuvant Radiation Therapy and Lymph Node Dissection in Pancreatic Cancer: A SEER Analysis

Authors: Mellon, E. Springett, G.M. Chuong, M.D. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2012 Supplement, Vol. 84, pS323-S324. 0p.

Surgery and Adjuvant Therapy in Gallbladder Cancer: A Single-Institutional Experience.

Authors: Kothari, N. Kim, R. Springett, G.M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pE150-E151. 1p.

Subjects: Oncologic surgery, Adjuvant treatment of cancer, Gallbladder cancer, Bladder cancer treatment, Cancer radiotherapy

Age and Resected Pancreatic Cancer Outcomes.

Authors: Freilich, J. Strom, T. Springett, G.M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS356-S356. 1p.

Subjects: Pancreatic cancer treatment, Age factors in disease, Health outcome assessment, Cancer-related mortality, Proportional hazards models, Multivariate analysis

Radiosensensitivity Index Shows Promise for Predicting Outcomes With Adjuvant Radiation in Resected Pancreatic Cancer Patients.

Authors: Shridhar, R. Strom, T. Springett, G.M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS174-S174. 1p.

Subjects: Cancer patients, Pancreatic cancer, Radiation-sensitizing agents, Cancer radiotherapy, Adjuvant treatment of cancer, Surgical excision, Medical physics

Predictors and Survival for Pathologic Tumor Response Grade in Borderline Resectable and Locally Advanced Pancreatic Cancer Treated With Induction Chemotherapy and Neoadjuvant Stereotactic Body Radiation Therapy.

Authors: Mellon, E.A. Hoffe, S.E. Frakes, J.M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE165-E165. 1p.

Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker.

Authors: Pearson, A.L. Jin, W. Mellon, E.A. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE153-E153. 1p.

Does Metabolic Tumor Volume Predict Tumor Regression Grade After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer?

Authors: Jin, W. Mellon, E.A. Hoffe, S.E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pE195-E195. 1p.

Favorable Perioperative and Survival Outcomes After Resection of Borderline Resectable Pancreatic Cancer Treated With Neoadjuvant Stereotactic Radiation and Chemotherapy Compared With Upfront Pancreatectomy for Resectable Cancer.

Authors: Mellon, E.A. Strom, T. Hoffe, S.E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pS154-S154. 1p.

Improved Overall Survival With Adjuvant Radiation on Resected Pancreatic Tail Adenocarcinoma.

Authors: Frakes, J.M. Shridhar, R. Strom, T. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pE128-E129. 1p.

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer: Updated Outcomes and Toxicity in Over 100 Patients.

Authors: Mellon, E.A. Hoffe, S.E. Freilich, J.M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS359-S360. 1p.

Stereotactic Body Radiation Therapy (SBRT) for Borderline Resectable and Locally Advanced Pancreatic Cancer is Effective and Well Tolerated

Authors: Chuong, M.D. Park, C.K. Mellon, E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2012 Supplement, Vol. 84, pS12-S13. 0p.

PET/CT Response Predicts Histopathologic Response after Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

Authors: Chuong, M.D. Hoffe, S.E. Shridhar, R. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2011 Supplement, Vol. 81 Issue 2, pS334-S335. 0p.

3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer

Authors: Chuong, M.D. Hayman, T.J. Patel, M.R. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2010 Supplement 1, Vol. 78 Issue 3, pS301-S301. 1p.